Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors

Published:2016-10 Issue: Volume:121 Page:294-299
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Li Jie,Wang Peiqi,Zhou Bihui,Shi Jianyou,Liu Jie,Li Xiangrong,Fan Limei,Zheng Yaxin,Ouyang Liang

Funder

National Natural Science Foundation of China

Young Scholars of Sichuan University

Hangzhou Science and Technology Information Institute of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference23 articles.

1. Histone recognition and large-scale structural analysis of the human bromodomain family;Filippakopoulos;Cell,2012

2. Scaling the druggability landscape of human bromodomains, a new class of drug targets;Zhang;J. Med. Chem.,2012

3. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation;Wu;J. Biol. Chem.,2007

4. Targeting MYC dependence in cancer by inhibiting BET bromodomains;Mertz;Proc. Natl. Acad. Sci. U. S. A.,2011

5. BET bromodomain inhibition as a therapeutic strategy to target c-Myc;Delmore;Cell,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis;European Journal of Medicinal Chemistry;2024-02

2. Research Progress in Antineoplastic, Antibacterial, and Anti-inflammatory Activities of Seven-membered Heterocyclic Derivatives;Current Medicinal Chemistry;2022-09

3. Discovery of 2-((2-methylbenzyl)thio)-6-oxo-4-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carbonitrile as a novel and effective bromodomain and extra-terminal (BET) inhibitor for the treatment of sepsis;European Journal of Medicinal Chemistry;2022-08

4. Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development;Journal of Medicinal Chemistry;2022-03-24

5. Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors;Molecules;2021-08-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3